Search clinical trials for: Aripiprazole, olanzapine and risperidone (Antipsychotics)

Total 2630 results

Central South University

Unknown

Antipsychotic to Treat Psychosis Syndrome

Psychotic Disorders

China
Janssen Korea, Ltd., Korea

Terminated

A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

Schizophrenia

Korea, Republic of
University of Pittsburgh
Janssen Pharmaceuticals

Completed

Risperdal Consta for Bipolar Disorder

Bipolar I Disorder

United States
Centre Hospitalier Universitaire de Nice

Completed

Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic

Schizophrenia | Dissociative Disorders

France
Veterans Medical Research Foundation
Bristol-Myers Squibb

Completed

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

Diabetes

United States
Peking University

Not yet recruiting

The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset

Treatment-resistant Schizophrenia
Sumitomo Pharma America, Inc.

Completed

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Schizophrenia

United States
Sumitomo Pharma America, Inc.

Completed

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Schizophrenia

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Metabolic Effects of Antipsychotics in Children (MEAC)

Aggression | Bipolar Disorder | Oppositional Defiant Disorder | Pervasive Development Disorders | Attention Deficit-Hyperactivity

United States
Cliniques universitaires Saint-Luc- Université...

Completed

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS (SANAT)

Schizophrenia

Belgium
Matt Byerly
Otsuka America Pharmaceutical

Unknown

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Schizophrenia

United States
Denovo Biopharma LLC

Completed

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Schizophrenia

United States, Mexico, Germany, Russian Federation
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

SWitching to Abilify Trial (SWAT)

Schizophrenia

Korea, Republic of
Janssen Research & Development, LLC

Completed

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Depressive Disorder | Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States, Belgium, Germany, Spain, Argentina, Brazil, Bulgaria
Inje University

Unknown

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Schizophrenia

Korea, Republic of
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Terminated

A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Schizophrenia | Metabolic Syndrome

France, Hungary, Spain, Czech Republic, Belgium, Germany, Greece, Switzerland, Turkey
Qingyun Yin

Unknown

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia (TAAS)

Schizophrenia

China
National Center for Research Resources (NCRR)
Washington University School of Medicine; Janssen, LP

Unknown

Glucose Regulation During Risperidone and Olanzapine Treatment

Schizophrenia

United States
Beijing HuiLongGuan Hospital

Completed

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

Schizophrenia
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Neuroleptic-Induced Tardive Dyskinesia

Taiwan
Peking University
Ministry of Science and Technology of the People´s Republic of China

Unknown

Standard Comprehensive Intervention to Treat First-episode Schizophrenia

Schizophrenia

China
Ohio State University

Recruiting

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Treatment-resistant Schizophrenia

United States
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Schizophrenia | Extrapyramidal Syndrome

Taiwan
All India Institute of Medical Sciences, Bhubaneswar

Not yet recruiting

EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIAL (versus)

The Goal of This Trial is to to Compare the Effect of Risperidone vs Aripiprazole in Terms of Change in Serum Glutathione Level
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" (SWITCH)

Schizophrenia

Italy
Ortho-McNeil Janssen Scientific Affairs, LLC

Withdrawn

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Schizophrenia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States, Russian Federation, Argentina
Centre for Addiction and Mental Health
Janssen Inc.

Recruiting

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Schizophrenia | Schizophrenia Relapse

Canada
Washington University School of Medicine
Janssen, LP

Completed

Janssen - Glucose Regulation/Risp/Olanz

Schizophrenia | Type 2 Diabetes Mellitus

United States
Massachusetts General Hospital

Completed

Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder

Bipolar Disorder | Mania

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Janssen Scientific Affairs, LLC

Completed

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Schizophrenia

United States, Puerto Rico
AstraZeneca
University of North Carolina

Completed

CAFE Comparison of Atypicals in First Episode of Psychosis

Mental Disorders | Psychotic Disorders | Schizophrenia | Mental Health

United States, Canada
Vanderbilt University

Completed

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Schizophrenia Trial of Aripiprazole

Schizophrenia

Austria, United Kingdom, France, Spain, Sweden, Czech Republic, Denmark, Finland, Germany
Vanderbilt University Medical Center

Recruiting

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Autism Spectrum Disorder | Weight Gain | Medication Side Effect

United States
Dalian Seventh People's Hospital
TAKARA BIOTECHNOLOGY(DALIAN)CO.,LTD.

Unknown

The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients

Schizophrenia | Micrognathia

China
Northwell Health
National Institutes of Health (NIH)

Completed

Striatal Connectivity and Clinical Outcome in Psychosis

Psychotic Disorders

United States
Centre for Addiction and Mental Health

Completed

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Delusional Disorder | Psychotic Disorder

Canada
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH); Pfizer

Completed

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Schizophrenia | Insulin Resistance | Metabolic Syndrome X

United States
University of Minnesota
AstraZeneca; Jensen, Jonathan B., M.D.

Completed

A Comparative Study of New Medications for Psychosis in Adolescents

Psychotic Disorders | Schizophrenia | Schizoaffective Disorders | Schizophreniform Disorders

United States
Central South University
Shanghai Mental Health Center; Capital Medical University; Nanjing Medical University and other collaborators

Completed

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia (ACPIOS)

Schizophrenia

China
Juntendo University

Completed

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Schizophrenia Relapse
Yale University
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Schizophrenia
Nathan Kline Institute for Psychiatric Research
Eli Lilly and Company

Completed

Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism

Hyperglycemia | Diabetes | Schizophrenia | Metabolic Syndrome

United States
Eli Lilly and Company

Completed

Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Centre for Addiction and Mental Health
Canadian Psychiatric Research Foundation

Completed

Antipsychotic Polypharmacy in Schizophrenia

Schizophrenia

Canada
University of Maryland, Baltimore

Terminated

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder (PAMS)

Bipolar Disorder

United States

Search clinical trials for: Aripiprazole, olanzapine and risperidone (Antipsychotics)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations